204
Participants
Start Date
September 20, 2017
Primary Completion Date
April 13, 2018
Study Completion Date
April 13, 2018
Cardiva Mid-Bore VVCS
The device will be used to close all femoral venous access sites at the end of the case, which range from 3 - 4 access sites per patient.
Manual compression
Manual compression will be used to achieve hemostasis in all femoral venous access sites when the sheaths are pulled, which range from 3-4 access sites per patient.
Mount Sinai Hospital, New York
Medstar Washington Hospital Center, Washington D.C.
Emory St. Joseph's Hospital, Atlanta
Centennial Medical Center, Nashville
Advocate Christ Medical Center, Oak Lawn
University of Chicago, Chicago
Texas Cardiac Arrhythmia Research Foundation, Austin
Intermountain Health Care, Murray
University of Utah Health Sciences Center, Salt Lake City
Stanford University Hospital, Stanford
Mercy General Hospital, Sacramento
Alaska Heart & Vascular, Anchorage
The Valley Hospital, Ridgewood
Lead Sponsor
Cardiva Medical, Inc.
INDUSTRY